Sflomos G - Search Results

1

SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking.

Kostaras E, Sflomos G, Pedersen NM, Stenmark H, Fotsis T, Murphy C. Kostaras E, et al. Among authors: sflomos g. Oncogene. 2013 Oct 31;32(44):5220-32. doi: 10.1038/onc.2012.554. Epub 2012 Dec 10. Oncogene. 2013. PMID: 23222715

2

ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN.

Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS, Fotsis T, Murphy C. Sflomos G, et al. J Cell Sci. 2011 Oct 1;124(Pt 19):3209-22. doi: 10.1242/jcs.062307. Epub 2011 Aug 30. J Cell Sci. 2011. PMID: 21878490

3

The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein.

Karetsou Z, Martic G, Sflomos G, Papamarcaki T. Karetsou Z, et al. Among authors: sflomos g. Biochem Biophys Res Commun. 2005 Sep 23;335(2):322-7. doi: 10.1016/j.bbrc.2005.06.210. Biochem Biophys Res Commun. 2005. PMID: 16061203

4

A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.

Sflomos G, Dormoy V, Metsalu T, Jeitziner R, Battista L, Scabia V, Raffoul W, Delaloye JF, Treboux A, Fiche M, Vilo J, Ayyanan A, Brisken C. Sflomos G, et al. Cancer Cell. 2016 Mar 14;29(3):407-422. doi: 10.1016/j.ccell.2016.02.002. Epub 2016 Mar 3. Cancer Cell. 2016. PMID: 26947176 Free article.

5

An ex vivo model to study hormone action in the human breast.

Sflomos G, Shamsheddin M, Brisken C. Sflomos G, et al. J Vis Exp. 2015 Jan 8;(95):e52436. doi: 10.3791/52436. J Vis Exp. 2015. PMID: 25590412 Free PMC article.

6

Progesterone/RANKL is a major regulatory axis in the human breast.

Tanos T, Sflomos G, Echeverria PC, Ayyanan A, Gutierrez M, Delaloye JF, Raffoul W, Fiche M, Dougall W, Schneider P, Yalcin-Ozuysal O, Brisken C. Tanos T, et al. Among authors: sflomos g. Sci Transl Med. 2013 Apr 24;5(182):182ra55. doi: 10.1126/scitranslmed.3005654. Sci Transl Med. 2013. PMID: 23616122 Free article.

7

A new Achilles Heel in breast cancer?

Sflomos G, Brisken C. Sflomos G, et al. Oncotarget. 2013 Aug;4(8):1126-7. doi: 10.18632/oncotarget.1178. Oncotarget. 2013. PMID: 23907591 Free PMC article. No abstract available.

8

Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor.

Scabia V, Ayyanan A, De Martino F, Agnoletto A, Battista L, Laszlo C, Treboux A, Zaman K, Stravodimou A, Jallut D, Fiche M, Bucher P, Ambrosini G, Sflomos G, Brisken C. Scabia V, et al. Among authors: sflomos g. Nat Commun. 2022 Jun 6;13(1):3127. doi: 10.1038/s41467-022-30898-0. Nat Commun. 2022. PMID: 35668111 Free PMC article.

9

The challenges of modeling hormone receptor-positive breast cancer in mice.

Özdemir BC, Sflomos G, Brisken C. Özdemir BC, et al. Among authors: sflomos g. Endocr Relat Cancer. 2018 May;25(5):R319-R330. doi: 10.1530/ERC-18-0063. Epub 2018 Mar 21. Endocr Relat Cancer. 2018. PMID: 29563191 Review.

10

Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.

Fiche M, Scabia V, Aouad P, Battista L, Treboux A, Stravodimou A, Zaman K; RLS; Dormoy V, Ayyanan A, Sflomos G, Brisken C. Fiche M, et al. Among authors: sflomos g. J Pathol. 2019 Mar;247(3):287-292. doi: 10.1002/path.5200. Epub 2018 Dec 27. J Pathol. 2019. PMID: 30430577 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page